From: AKAP3 correlates with triple negative status and disease free survival in breast cancer
Variable | AKAP3 expression | p value | AKAP3 expression | p value | ||
---|---|---|---|---|---|---|
Ā | In tumor | Ā | In normal | Ā | ||
Ā | Negative no (%) | Positive no (%) | Ā | Negative no (%) | Positive no (%) | Ā |
ER | ||||||
āāāNegative | 27 (67.5) | 13 (32.5) | 0.4 | 21 (55.3) | 17 (44.7) | 0.5 |
āāāPositive | 20 (62.5) | 12 (37.5) | Ā | 17 (53.1) | 15 (46.9) | Ā |
PR | ||||||
āāāNegative | 30 (63.8) | 17 (36.2) | 0.4 | 24 (53.3) | 21 (46.7) | 0.5 |
āāāPositive | 17 (68) | 8 (32) | Ā | 14 (56) | 11 (44) | Ā |
Her2 | ||||||
āāāNegative | 34 (68) | 16 (32) | 0.3 | 25 (51) | 24 (49) | 0.2 |
āāāPositive | 13 (59.1) | 9 (40.9) | Ā | 13 (61.9) | 8 (38.1) | Ā |
Tumor Grade | ||||||
āāā1 | 3 (50) | 3 (50) | 0.7 | 3 (50) | 3 (50) | 0.9 |
āāā2 | 21 (61.8) | 13 (38.2) | Ā | 18 (52.9) | 16 (47.1) | Ā |
āāā3 | 18 (66.7) | 9 (33.3) | Ā | 14 (56) | 11 (44) | Ā |
Lymph Node | ||||||
āāāNo | 15 (68.2) | 7 (31.8) | 0.7 | 10 (45.5) | 12 (54.5) | 0.3 |
āāā1-3 | 13 (56.5) | 10 (43.5) | Ā | 11 (47.8) | 12 (52.2) | Ā |
āāā4-9 | 8 (57.1) | 6 (42.9) | Ā | 9 (75) | 3 (25) | Ā |
āāā>9 | 7 (70) | 3 (30) | Ā | 6 (60) | 4 (40) | Ā |
Tumor size | ||||||
āāāā¤2cm | 10 (41.7) | 14 (58.3) | 0.01 | 13 (54.2) | 11 (45.8) | 0.5 |
āāā>2Ā cm | 32 (72.7) | 12 (27.3) | Ā | 23 (54.8) | 19 (45.2) | Ā |
Stage | ||||||
āāāI | 1 (14.3) | 6 (85.7) | 0.04 | 2 (28.6) | 5 (71.4) | 0.2 |
āāāII | 22 (66.7) | 11 (33.3) | Ā | 16 (48.5) | 17 (51.5) | Ā |
āāāIII | 14 (66.7) | 7 (33.3) | Ā | 12 (63.2) | 7 (36.8) | Ā |
āāāIV | 6 (75) | 2 (25) | Ā | 6 (75) | 2 (25) | Ā |
Subtype | ||||||
āāāTriple Negative | 20 (80) | 5 (20) | 0.03 | 13 (54.2) | 11 (45.8) | 0.5 |
āāāOther types | 27 (56.3) | 21 (43.8) | Ā | 26 (55.3) | 21 (44.7) | Ā |
Patient status | ||||||
āāāNo event | 31 (63.3) | 18 (36.7) | 0.5 | 19 (41.3) | 27 (58.7) | 0.003 |
āāāWith event | 14 (66.7) | 7 (33.3) | Ā | 16 (80) | 4 (20) | Ā |